MedTrace Logo

Predictors of Exposure Success in Public Speaking Anxiety

NCT02163148 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2015-05-27

No results posted yet for this study

Summary

Anxiety disorders are common and impairing. Although exposure therapy is one of the most effective treatments for anxiety, some individuals do not fully respond to treatment, and these individual differences are not well understood. Exposure therapy involves repeated, deliberate, safe engagement with a feared stimulus without the feared outcome occurring. This treatment is thought to work through a type of emotional learning called fear extinction. This study aims to look at links between fear extinction learning and exposure success, with the overall goal of better understanding who is likely to respond best to exposure therapy and why.

Conditions

  • Performance Anxiety

Interventions

BEHAVIORAL

Massed speech exposure session

One session consisting of 4 speech exposures, each 5 minutes long.

Sponsors & Collaborators

Principal Investigators

  • Tali M Ball, MA · UCSD

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02163148 on ClinicalTrials.gov